ClinicalTrials.gg

Beijing Biotech clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 32 studies whose lead sponsor is Beijing Biotech. 32 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 12, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare Beijing Biotech with AstraZeneca and Jiangsu HengRui Medicine →

Pipeline: 40 programs

Each counted once: 40 with a study Beijing Biotech leads registered in the last two years.

  • Phase 1
  • Phase 2

5 from the earlier phases, besides the phase-3 view.

Program
CyclophosphamidePhase 2 · 9 live · Breast Neoplasms · primary completion Feb 2027☆ Track
fludarabinePhase 2 · 9 live · Leukemia, Lymphocytic, Chronic, B-Cell · primary completion Feb 2027☆ Track
Dual-target CAR-NK cellsPhase 2 · 5 live · Glioblastoma · primary completion Feb 2027☆ Track
ebnk-1822h2 dual-target cldn18.2CLDN18Phase 2 · 3 live · Neoplasm Metastasis · primary completion Feb 2027☆ Track
Lymphodepleting chemotherapyPhase 2 · 3 live · Small Cell Lung Carcinoma · primary completion Feb 2027☆ Track

35 more — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Beijing Biotech’s own registered studies; Beijing Biotech’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Beijing Biotech’s studies test, most open studies first — 3 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

31 of Beijing Biotech’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. 8F
  5. 15M
  6. 4A
  7. M
  8. 4J
  9. J
  10. A
  11. S
  12. O
  13. N

Add all 31 to your calendar (.ics) → With an account.

All 32 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now32100%

Phase

Where

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Beijing Biotech.

  • Beijing Biotech
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    32 studies

Studies

Recruiting first, then most recently updated. Showing 32 of 32.